Magnify Magazine

Media Resources

Media Contact

Bonnie Stray
media@aruplab.com
801-583-2787 ext 2823

LabMind podcasts

View Factsheet PDF

Stew and Becky Tribe hold their newborn son, Woodward, who was the first baby in Utah to be diagnosed with GAMT deficiency through Utah’s newborn test panel. Utah is one of only three states that include this screening for newborns.	January 11, 2021	ARUP-Developed Newborn Test Dramatically Changes Baby’s Life—But It Almost Didn’t Happen Utah added screening for GAMT deficiency to its NBS panel in 2015, becoming the first state to do so. It is now one of only three states to screen for the condition.
	January 7, 2021	ARUP Expert Joins Industry Peers to Explore How COVID-19 Has Accelerated Diagnostic Innovation Which types of innovation, adaptation, and acceleration happened in diagnostic technology companies in the face of the COVID-19 pandemic? Are the intensity and fast-moving strategies even sustainable?
	January 6, 2021	ARUP Releases Comprehensive New Resource to Help Clinicians Choose the Right Tests or Thyroid Disease To assist clinicians in providing the best possible care for patients with thyroid disease, ARUP Laboratories has released a comprehensive new thyroid disease testing resource on ARUP Consult.
	January 5, 2021	ARUP R&D Expert Participates in Silicon Slopes Event Covering Utah’s Response to COVID-19 Adam Barker, PhD, director of the ARUP Institute for Clinical & Experimental Pathology, is among medical experts who will participate in an event that will examine Utah’s response to COVID-19.
	January 4, 2021	Webinar Available for Free Continuing Education Credit Answers SARS-CoV-2 Testing Questions A recording of an hour-long webinar updating the status of diagnostic testing for SARS-CoV-2 nearly a year after the first tests were introduced is now available to watch for free.
	December 30, 2020	ARUP Researchers Played Key Role in Newborn Screening That Identified Baby Born with GAMT Deficiency In December 2020, Utah’s Newborn Screening Program identified the first patient with guanidinoacetate methyltransferase (GAMT) deficiency solely through newborn screening.